Arrowhead Pharmaceuticals
ARWR
#2125
Rank
HK$74.09 B
Marketcap
HK$529.11
Share price
-4.70%
Change (1 day)
429.67%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): HK$2.66

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$2.74. an increase over its 2024 EPS that were of -HK$39.13.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-HK$0.07825-99.8%
2024-HK$39.13161.39%
2023-HK$14.9717.36%
2022-HK$12.7519.85%
2021-HK$10.6461.9%
2020-HK$6.57-216.67%
2019HK$5.63-210.77%
2018-HK$5.0938.3%
2017-HK$3.68-64.93%
2016-HK$10.49-16.25%
2015-HK$12.5228%
2014-HK$9.78-3.85%
2013-HK$10.17-31.58%
2012-HK$14.87331.82%
2011-HK$3.44-51.11%
2010-HK$7.04-79.07%
2009-HK$33.65-37.68%
2008-HK$53.99-16.87%
2007-HK$64.9538.33%
2006-HK$46.95122.22%
2005-HK$21.1342.11%
2004-HK$14.87533.33%
2003-HK$2.35-99.08%
2002-HK$254.0725%
2001-HK$203.2533.33%
2000-HK$152.44-120%
1999HK$762.20-400%
1998-HK$254.07-81.48%
1997-HK$1,372

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.16 3,082.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$56.89-2,177.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$49.30 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$14.09 414.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$22.54-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA